FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2636011000001101: Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24916701000001116 Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54501201000001117 Moclobemide 300mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 2 x 15 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Is a Moclobemide 300mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Is pack of Moclobemide 300mg tablets (Unichem Plc) false Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has active ingredient Moclobemide false Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has AMP Moclobemide 300mg tablets (Unichem Plc) true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has specific active ingredient Moclobemide true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start